Application of Opaganib in preparation of anti-aging product
By using Opaganib to inhibit the expression of inflammatory factors and genes, the expression of p-CREB protein and neural function-related genes is improved, and the problem of degradation of learning and memory abilities in the elderly is solved, and the effect of improving learning, memory abilities and prolonging lifespan is achieved.
CN119700758APending Publication Date: 2025-03-28SUN YAT SEN UNIV
4 Cites 0 Cited by
Patent Information
- Application Number
- CN202411688327.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-11-25
- Publication Date
- 2025-03-28
AI Technical Summary
Technical Problem
At present, there has been no reports on the application of Opaganib in the preparation of anti-aging products, and the problem of degradation in learning and memory ability in the elderly has not been effectively solved.
Method used
Opaganib is used as the main component to increase the content of p-CREB protein and the protein expression of neural function-related genes by inhibiting the expression of serum inflammatory factors and brain inflammation-related genes, thereby improving the learning, memory ability and prolonging life span of the elderly.
Benefits of technology
Experimental results show that Opaganib can significantly inhibit the expression of inflammatory factors and genes, improve learning and memory capabilities, and extend the lifespan of mice.
✦ Generated by Eureka AI based on patent content.
Abstract
The invention belongs to the technical field of medicines, and relates to application of Opaganib in preparation of anti-aging products. And the structural formula of the Opaganib is as shown in formula I: # imgabs0 #. The invention provides a thought for developing a new product for improving the learning and memory ability of the old people and prolonging the life of the old people.
Need to check novelty before this filing date? Find Prior Art